Clinical trial
Genomic Outcomes of Metformin
NCT02986659 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genomic Outcomes of Metformin
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 3, 2016
- Completion date
- November 15, 2018
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, hypertension, mild cognitive impairment, obesity, abdominal